Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Amneal Pharmaceuticals, Inc. AMRX
$1.87
-$0.01 (-0.53%)
На 18:01, 12 мая 2023
+113.90%
Потенциал через год
Ранг: 2
Ключевые показатели
-
Marketcap
569632523.00000000
-
week52high
3.77
-
week52low
1.24
-
Revenue
2212304000
-
P/E TTM
-1
-
Beta
1.31664900
-
EPS
-0.83000000
-
Last Dividend
0.00000000
-
Next Earnings Date
05 мая 2023 г. в 12:30
Описание компании
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals across a range of therapeutic categories. The Specialty segment is involved in the development, promotion, distribution, and sale of branded pharmaceutical products with focus on central nervous system disorders, endocrinology, parasitic infections, and other therapeutic areas. It also offers Emverm, a chewable tablet for the treatment of pinworm, whipworm, common roundworm, common hookworm, and American hookworm in single or mixed infections; Rytary to treat Parkinson's disease; and Unithroid for the treatment of hypothyroidism. The AvKARE segment provides pharmaceuticals, medical and surgical products, and services primarily to governmental agencies, the Department of Defense, and the Department of Veterans Affairs. It is also involved in the wholesale distribution of bottle and unit dose pharmaceuticals under the AvKARE and AvPAK names, as well as medical and surgical products; and packaging and wholesale distribution of pharmaceuticals and vitamins to its retail and institutional customers. The company sells its products through wholesalers, distributors, hospitals, chain pharmacies, and individual pharmacies. It operates in the United States, India, Ireland, and internationally. The company was formerly known as Atlas Holdings, Inc. and changed its name to Amneal Pharmaceuticals, Inc. in 2018. Amneal Pharmaceuticals, Inc. was founded in 2002 and is headquartered in Bridgewater, New Jersey.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Goldman Sachs | Buy | Buy | 08 авг 2022 г. |
| Goldman Sachs | Buy | Buy | 12 мая 2022 г. |
| Goldman Sachs | Buy | Sell | 08 мар 2021 г. |
| Guggenheim | Buy | Neutral | 14 дек 2020 г. |
| SVB Leerink | Market Perform | Market Perform | 09 ноя 2020 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| TPG GP A, LLC | D | 12328767 | 3884600 | 12 дек 2022 г. |
| Pesquin Gustavo | A | 444444 | 444444 | 06 сент 2022 г. |
| Autor Deborah M. | A | 54949 | 54949 | 29 июл 2022 г. |
| BOYER ANDREW S | D | 23095 | 23094 | 30 июн 2022 г. |
| BOYER ANDREW S | D | 208096 | 11582 | 30 июн 2022 г. |
| BOYER ANDREW S | A | 219678 | 23094 | 30 июн 2022 г. |
| Patel Gautam | A | 80128 | 80128 | 09 мая 2022 г. |
| Patel Gautam | A | 0 | 35406 | 09 мая 2022 г. |
| Yanai Shlomo | A | 80128 | 80128 | 09 мая 2022 г. |
| Yanai Shlomo | A | 0 | 35406 | 09 мая 2022 г. |
Новостная лента
Amneal Pharmaceuticals' stock soars 14% premarket after company offers upbeat Q1 guidance
Market Watch
17 апр 2023 г. в 06:53
Amneal Pharmaceuticals Inc.'s stock AMRX, -2.16% soared 14% in premarket trade Monday, after the generics and specialty pharmaceuticals company offered first-quarter guidance that topped consensus estimates. Bridgewater, N.J.
Generic drugs are most likely to face shortages due to market failures in affordability
CNBC Television
29 мар 2023 г. в 17:26
CNBC's Meg Tirrell joins 'Closing Bell Overtime' to discuss growing pharmaceutical shortages, increasing debt hindering generic drug availability, and more.
Amneal Pharmaceuticals (AMRX) Beats Q4 Earnings and Revenue Estimates
Zacks Investment Research
02 мар 2023 г. в 09:02
Amneal (AMRX) delivered earnings and revenue surprises of 9.52% and 4.91%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Best Penny Stocks To Buy? 4 Stocks Under $3 To Watch This Week
PennyStocks
13 февр 2023 г. в 14:47
Penny stocks under $3 to watch this week. The post Best Penny Stocks To Buy?
Intercept Surges To Four-Month High After Staving Off Amneal's Generic For 11 Years
Investors Business Daily
25 янв 2023 г. в 13:15
Intercept reached a settlement with Amneal that delays a generic version of its only product. In response, ICPT stock surged Wednesday.